ANDA 090450

AKORN

FDA Drug Application

Application #090450

Application Sponsors

ANDA 090450

AKORN

Marketing Status

• Prescription: 001
• Prescription: 002

Application Products

001	SOLUTION;INTRAVENOUS	60MG/20ML (3MG/ML)	0	ADENOSINE	ADENOSINE
002	SOLUTION;INTRAVENOUS	90MG/30ML (3MG/ML)	0	ADENOSINE	ADENOSINE

FDA Submissions

ORIG

1

AP

2014-10-02

Submissions Property Types

ORIG

1

Null

15

TE Codes

001	Prescription	AP
002	Prescription	AP

CDER Filings

AKORN

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90450
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"ADENOSINE","activeIngredients":"ADENOSINE","strength":"60MG\/20ML (3MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ADENOSINE","activeIngredients":"ADENOSINE","strength":"90MG\/30ML (3MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ADENOSINE","submission":"ADENOSINE","actionType":"60MG\/20ML (3MG\/ML)","submissionClassification":"SOLUTION;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"ADENOSINE","submission":"ADENOSINE","actionType":"90MG\/30ML (3MG\/ML)","submissionClassification":"SOLUTION;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)